Alpha-2 agonists in the treatment of attention deficit hyperactivity disorder.
Scahill
L
L
Yale Child Study Center, New Haven, CT, USA. lawrence.scahill@yale.edu
Barloon
L
L
Farkas
L
L
D058647:Adrenergic alpha-2 Receptor Agonists; D000316:Adrenergic alpha-Agonists / Q000627:therapeutic use*; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy*; D000697:Central Nervous System Stimulants / Q000009:adverse effects; D002648:Child; D003000:Clonidine / Q000627:therapeutic use*; D016316:Guanfacine / Q000627:therapeutic use*; D006801:Humans; D008125:Locus Coeruleus / Q000187:drug effects; D017397:Prefrontal Cortex / Q000187:drug effects; D020323:Tics / Q000139:chemically induced; D016896:Treatment Outcome
D058647:Adrenergic alpha-2 Receptor Agonists; D000316:Adrenergic alpha-Agonists; D000697:Central Nervous System Stimulants; D016316:Guanfacine; D003000:Clonidine